These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 21072291

  • 1. Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal.
    Cesareo R, Napolitano C, Iozzino M.
    Int J Womens Health; 2010 Aug 09; 2():1-6. PubMed ID: 21072291
    [Abstract] [Full Text] [Related]

  • 2. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
    Ortolani S, Vai S.
    Bone; 2006 Feb 09; 38(2 Suppl 1):19-22. PubMed ID: 16455319
    [Abstract] [Full Text] [Related]

  • 3. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
    Reginster JY, Deroisy R, Jupsin I.
    Drugs Today (Barc); 2003 Feb 09; 39(2):89-101. PubMed ID: 12698204
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis.
    Deeks ED, Dhillon S.
    Drugs; 2010 Apr 16; 70(6):733-59. PubMed ID: 20394457
    [Abstract] [Full Text] [Related]

  • 6. Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.
    Meunier PJ, Roux C, Ortolani S, Diaz-Curiel M, Compston J, Marquis P, Cormier C, Isaia G, Badurski J, Wark JD, Collette J, Reginster JY.
    Osteoporos Int; 2009 Oct 16; 20(10):1663-73. PubMed ID: 19153678
    [Abstract] [Full Text] [Related]

  • 7. Spotlight on strontium ranelate: in postmenopausal osteoporosis.
    Deeks ED, Dhillon S.
    Drugs Aging; 2010 Sep 01; 27(9):771-3. PubMed ID: 20809666
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
    Adami S.
    Bone; 2006 Feb 01; 38(2 Suppl 1):23-7. PubMed ID: 16434247
    [Abstract] [Full Text] [Related]

  • 11. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.
    Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ.
    J Clin Endocrinol Metab; 2005 May 01; 90(5):2816-22. PubMed ID: 15728210
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Strontium ranelate in osteoporosis.
    Reginster JY.
    Curr Pharm Des; 2002 May 01; 8(21):1907-16. PubMed ID: 12171530
    [Abstract] [Full Text] [Related]

  • 17. Strontium ranelate: a novel mode of action leading to renewed bone quality.
    Ammann P.
    Osteoporos Int; 2005 Jan 01; 16 Suppl 1():S11-5. PubMed ID: 15578157
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Strontium ranelate: a new treatment for postmenopausal osteoporosis with a dual mode of action.
    Reginster JY, Sarlet N, Lejeune E, Leonori L.
    Curr Osteoporos Rep; 2005 Mar 01; 3(1):30-4. PubMed ID: 16036099
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.